The Use of Sodium DL-3-Hydroxybutyrate in Severe Acute Neuro-Metabolic Compromise in Patients With Inherited Ketone Body Synthetic Disorders
Orphanet Journal of Rare Diseases - United Kingdom
doi 10.1186/s13023-020-1316-x
Full Text
Open PDFAbstract
Available in full text
Date
February 18, 2020
Authors
Publisher
Springer Science and Business Media LLC